Are patients with mild to moderate renal impairment on metformin or other oral anti-hyperglycaemic agents at increased risk of contrast-induced nephropathy and metabolic acidosis after radiocontrast exposure?

To investigate whether the use of metformin during computed tomography (CT) with radiocontrast agents increases the risk of contrast-induced nephropathy (CIN) and metabolic acidosis after CT in type 2 diabetes patients with mild to moderate renal failure.

Source: Clinical Radiology - June 11, 2019 Category: Radiology Authors: J. Jung, Y.Y. Cho, J.H. Jung, K.Y. Kim, H.S. Kim, J.-h. Baek, J.R. Hahm, H.S. Cho, S.K. Kim Source Type: research